Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
NCT 06712316 Brief Summary This is a Phase 2/3, multisite, randomized, open-label…
Read more arrow_forwardNCT 06712316 Brief Summary This is a Phase 2/3, multisite, randomized, open-label…
Read more arrow_forwardNCT 05997615 Brief Summary The study will be conducted in 4…
Read more arrow_forwardNCT 06120491 Brief Summary The intention of the study is to…
Read more arrow_forwardNCT 05261399 Brief Summary Clinical study to investigate the efficacy and…
Read more arrow_forwardNCT 05611931 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05480865 Brief Summary This is a Phase 1 study of BBP-398,…
Read more arrow_forwardNCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forwardNCT 03505229 Brief Summary To assess the freedom from local failure at…
Read more arrow_forwardNCT 04994717 Brief Summary The safety run-in part of the study…
Read more arrow_forwardNCT 03562637 Brief Summary The GLORIA study is a Phase III, randomized,…
Read more arrow_forward